At its present level of around $200, WST stock is trading at just 5.1x trailing revenue, compared to its five-year average ...
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...
West Pharmaceuticals stock drops 38% after ending glucose monitor contracts; CEO Eric Green says GLP-1 business will offset ...
Trade Desk sinks following a revenue miss, AppLovin surges after quarterly revenue soars 44%, and Intel extends the stock’s ...
West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...
Q4 2024 Management View CEO Eric Green highlighted that the company achieved 3.3% organic revenue growth in Q4 2024, marking a return to quarterly growth. Notable drivers included strong performance ...
Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a $250 price target Maximize Your Portfolio with Data Driven ...